Astellas Pharma Inc (ALPMY)
10.70
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
Astellas Pharma Shareholders Equity (Quarterly): 10.54B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 10.71B |
March 31, 2024 | 10.54B |
December 31, 2023 | 10.66B |
September 30, 2023 | 10.97B |
June 30, 2023 | 10.90B |
March 31, 2023 | 11.32B |
December 31, 2022 | 11.98B |
September 30, 2022 | 11.42B |
June 30, 2022 | 11.27B |
March 31, 2022 | 11.96B |
December 31, 2021 | 12.74B |
September 30, 2021 | 12.66B |
June 30, 2021 | 12.51B |
March 31, 2021 | 12.57B |
December 31, 2020 | 13.27B |
September 30, 2020 | 12.58B |
June 30, 2020 | 12.14B |
March 31, 2020 | 11.93B |
December 31, 2019 | 12.10B |
September 30, 2019 | 12.01B |
June 30, 2019 | 11.58B |
March 31, 2019 | 11.35B |
December 31, 2018 | 11.71B |
September 30, 2018 | 11.28B |
June 30, 2018 | 11.54B |
Date | Value |
---|---|
March 31, 2018 | 11.93B |
December 31, 2017 | 12.12B |
September 30, 2017 | 12.01B |
June 30, 2017 | 11.78B |
March 31, 2017 | 11.38B |
December 31, 2016 | 11.29B |
September 30, 2016 | 12.12B |
June 30, 2016 | 11.58B |
March 31, 2016 | 11.20B |
December 31, 2015 | 10.98B |
September 30, 2015 | 11.04B |
June 30, 2015 | 10.87B |
March 31, 2015 | 10.98B |
December 31, 2014 | 11.50B |
September 30, 2014 | 11.84B |
June 30, 2014 | 12.13B |
March 31, 2014 | 12.33B |
December 31, 2013 | 11.06B |
September 30, 2013 | 11.47B |
June 30, 2013 | 11.06B |
March 31, 2013 | 12.47B |
December 31, 2012 | 12.23B |
September 30, 2012 | 12.92B |
June 30, 2012 | 12.40B |
March 31, 2012 | 13.67B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.54B
Minimum
Mar 2024
13.27B
Maximum
Dec 2020
11.80B
Average
11.96B
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 92.29B |
Takeda Pharmaceutical Co Ltd | 48.46B |
Nxera Pharma Co Ltd | 428.64M |
PeptiDream Inc | 365.20M |
Healios KK | 20.16M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 23.58B |
Total Liabilities (Quarterly) | 13.04B |
Debt to Equity Ratio | 0.5765 |
Current Ratio | 0.9292 |
Net Debt Paydown Yield | 1.06% |